APA (7th ed.) Citation

Camarillo Cárdenas, K. P., García González, J., Argüelles Tello, F. A., Ocampo Ramírez, J. A., Moreno Hernández, J. B., & Pendela, M. M. (2022). Relative bioavailability and pharmacokinetic comparison of a fixed‐dose combination tablet of mosapride, pancreatin, and simethicone relative to single‐component mosapride tablets in healthy Mexican subjects. Fundamental & clinical pharmacology, 36(2), 427-435. https://doi.org/10.1111/fcp.12739

Chicago Style (17th ed.) Citation

Camarillo Cárdenas, Karen Paola, Jessica García González, Federico Alberto Argüelles Tello, Jorge Arturo Ocampo Ramírez, José Belisario Moreno Hernández, and Murali Mohan Pendela. "Relative Bioavailability and Pharmacokinetic Comparison of a Fixed‐dose Combination Tablet of Mosapride, Pancreatin, and Simethicone Relative to Single‐component Mosapride Tablets in Healthy Mexican Subjects." Fundamental & Clinical Pharmacology 36, no. 2 (2022): 427-435. https://doi.org/10.1111/fcp.12739.

MLA (9th ed.) Citation

Camarillo Cárdenas, Karen Paola, et al. "Relative Bioavailability and Pharmacokinetic Comparison of a Fixed‐dose Combination Tablet of Mosapride, Pancreatin, and Simethicone Relative to Single‐component Mosapride Tablets in Healthy Mexican Subjects." Fundamental & Clinical Pharmacology, vol. 36, no. 2, 2022, pp. 427-435, https://doi.org/10.1111/fcp.12739.